Bethanechol decreases reaction time in senile dementia of the Alzheimer type.
Bethanechol, a muscarinic cholinergic agonist, was injected subcutaneously in eight cases of senile dementia of the Alzheimer type. Simple reaction time was measured before, 15 min and 30 min following the injection. Before injection, the patients had significantly longer reaction time than non-demented controls. A significant shortening of the reaction time was observed 15 min but not 30 min after injection. A second group of eight patients with senile dementia of the Alzheimer type, matched for age and mental impairment were injected with saline. No significant shortening of the reaction time was observed. These results suggest that the reaction time can be shortened by a muscarinic agonist in dementia of the Alzheimer type.
D000328:Adult; D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D001626:Bethanechol Compounds / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D008875:Middle Aged; D019832:N-Methylscopolamine; D010276:Parasympatholytics / Q000627:therapeutic use; D011597:Psychomotor Performance / Q000187:drug effects; D011930:Reaction Time / Q000187:drug effects*; D012602:Scopolamine Derivatives / Q000627:therapeutic use
D001626:Bethanechol Compounds; D010276:Parasympatholytics; D012602:Scopolamine Derivatives; D019832:N-Methylscopolamine